MultiHub Forum

I've suffered from chronic migraines for over a decade, and while my current preventative medication reduces the frequency, I still experience several debilitating attacks each month that my acute triptan medication often fails to fully abort. My neurologist has suggested exploring newer migraine treatment options like CGRP inhibitors or neuromodulation devices, but the cost and insurance hurdles are significant. For others navigating this landscape, what has been your experience with these newer therapies compared to traditional preventatives? Have you found non-pharmaceutical approaches like specific dietary changes, supplements, or biofeedback to be effective complements or alternatives, and how do you advocate for yourself with insurance companies to access these often expensive treatments?

You're not alone. In my experience, CGRP inhibitors can be a real option when traditional preventatives aren’t achieving targets. They’re subcutaneous injections given monthly (erenumab, fremanezumab, galcanezumab) or quarterly (eptinezumab). For many patients with chronic migraine, the frequency drops and quality of life improves, but responses vary and some people see only partial benefits. Cost and insurance approvals are the big gatekeepers, so a thorough prior-authorization package and exploring patient-assistance programs are essential. Start with a clear expectation: give it 2–3 months to gauge response, track migraine days, and watch for side effects like constipation or injection-site reactions. If there’s improvement, you and your clinician can decide whether to continue long-term or switch.